Video Experimental Relacionado
Updated: Jan 7, 2026
07:43
Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.9K
Asociación entre la expresión de PD-L1 y el riesgo de enfermedad pulmonar intersticial en el NSCLC mutante en EGFR
Yutaka Takahara1, Ryudai Abe2, Sumito Nagae2
1Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa, Japan takahara@kanazawa-med.ac.jp.
In vivo (Athens, Greece)
|January 2, 2026
Resumen
No abstract available in PubMed .
Palabras clave:
Cáncer de pulmón no de células pequeñasreceptor del factor de crecimiento epidérmicoEnfermedades pulmonares intersticialesmutaciónligando de muerte programado 1Más Videos Relacionados
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.5K